Literature DB >> 30794836

GABAAR isoform and subunit structural motifs determine synaptic and extrasynaptic receptor localisation.

Saad Hannan1, Marielle Minere2, Joseph Harris2, Pablo Izquierdo2, Philip Thomas2, Becky Tench2, Trevor G Smart3.   

Abstract

GABAA receptors (GABAARs) are the principal inhibitory neurotransmitter receptors in the central nervous system. They control neuronal excitability by synaptic and tonic forms of inhibition mostly mediated by different receptor subtypes located in specific cell membrane subdomains. A consensus suggests that α1-3βγ comprise synaptic GABAARs, whilst extrasynaptic α4βδ, α5βγ and αβ isoforms largely underlie tonic inhibition. Although some structural features that enable the spatial segregation of receptors are known, the mobility of key synaptic and extrasynaptic GABAARs are less understood, and yet this is a key determinant of the efficacy of GABA inhibition. To address this aspect, we have incorporated functionally silent α-bungarotoxin binding sites (BBS) into prominent hippocampal GABAAR subunits which mediate synaptic and tonic inhibition. Using single particle tracking with quantum dots we demonstrate that GABAARs that are traditionally considered to mediate synaptic or tonic inhibition are all able to access inhibitory synapses. These isoforms have variable diffusion rates and are differentially retained upon entering the synaptic membrane subdomain. Interestingly, α2 and α4 subunits reside longer at synapses compared to α5 and δ subunits. Furthermore, a high proportion of extrasynaptic δ-containing receptors exhibited slower diffusion compared to δ subunits at synapses. A chimera formed from δ-subunits, with the intracellular domain of γ2L, reversed this behaviour. In addition, we observed that receptor activation affected the diffusion of extrasynaptic, but not of synaptic GABAARs. Overall, we conclude that the differential mobility profiles of key synaptic and extrasynaptic GABAARs are determined by receptor subunit composition and intracellular structural motifs. This article is part of the special issue entitled 'Mobility and trafficking of neuronal membrane proteins'.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30794836     DOI: 10.1016/j.neuropharm.2019.02.022

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  10 in total

1.  Thalamocortical bistable switch as a theoretical model of fibromyalgia pathogenesis inferred from a literature survey.

Authors:  Ilaria Demori; Giulia Giordano; Viviana Mucci; Serena Losacco; Lucio Marinelli; Paolo Massobrio; Franco Blanchini; Bruno Burlando
Journal:  J Comput Neurosci       Date:  2022-07-11       Impact factor: 1.453

2.  Differential Coassembly of α1-GABAARs Associated with Epileptic Encephalopathy.

Authors:  Saad Hannan; Aida H B Affandi; Marielle Minere; Charlotte Jones; Pollyanna Goh; Gary Warnes; Bernt Popp; Regina Trollmann; Dean Nizetic; Trevor G Smart
Journal:  J Neurosci       Date:  2020-06-08       Impact factor: 6.167

3.  Inhibitory Synapse Formation at the Axon Initial Segment.

Authors:  Anna J Nathanson; Paul A Davies; Stephen J Moss
Journal:  Front Mol Neurosci       Date:  2019-11-05       Impact factor: 5.639

4.  Inhibitory Receptor Diffusion Dynamics.

Authors:  Stephanie A Maynard; Antoine Triller
Journal:  Front Mol Neurosci       Date:  2019-12-19       Impact factor: 5.639

5.  MD2 contributes to the pathogenesis of perioperative neurocognitive disorder via the regulation of α5GABAA receptors in aged mice.

Authors:  Wenqiang Zuo; Jianshuai Zhao; Jinming Zhang; Zongping Fang; Jiao Deng; Ze Fan; Yaru Guo; Jing Han; Wugang Hou; Hailong Dong; Feifei Xu; Lize Xiong
Journal:  J Neuroinflammation       Date:  2021-09-16       Impact factor: 8.322

6.  Cellular and molecular signatures of in vivo imaging measures of GABAergic neurotransmission in the human brain.

Authors:  Paulina Barbara Lukow; Daniel Martins; Mattia Veronese; Anthony Christopher Vernon; Philip McGuire; Federico Edoardo Turkheimer; Gemma Modinos
Journal:  Commun Biol       Date:  2022-04-19

Review 7.  Regulation of Inhibitory Signaling at the Receptor and Cellular Level; Advances in Our Understanding of GABAergic Neurotransmission and the Mechanisms by Which It Is Disrupted in Epilepsy.

Authors:  Allison E Tipton; Shelley J Russek
Journal:  Front Synaptic Neurosci       Date:  2022-06-15

8.  Altered Behavioral Responses Show GABA Sensitivity in Muscleblind-Like 2-Deficient Mice: Implications for CNS Symptoms in Myotonic Dystrophy.

Authors:  Kamyra S Edokpolor; Anwesha Banerjee; Zachary T McEachin; Jingsheng Gu; Adam Kosti; Juan D Arboleda; Paul S García; Eric T Wang; Gary J Bassell
Journal:  eNeuro       Date:  2022-10-10

Review 9.  TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease.

Authors:  Mª Dolores Muñoz; Nerea de la Fuente; Amelia Sánchez-Capelo
Journal:  Int J Mol Sci       Date:  2020-01-16       Impact factor: 5.923

10.  Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome.

Authors:  Javier Zorrilla de San Martin; Cristina Donato; Jérémy Peixoto; Andrea Aguirre; Vikash Choudhary; Angela Michela De Stasi; Joana Lourenço; Marie-Claude Potier; Alberto Bacci
Journal:  Elife       Date:  2020-08-12       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.